424B5VKTXCIK 0001607678

Viking Therapeutics, Inc.

Name: SEC EDGAR filing 0001193125-26-401385
Creator: Viking Therapeutics, Inc.
License: https://www.usa.gov/government-works

Prospectus supplement (424B5) filed September 25, 2026.

Prospectus supplement filed under Rule 424(b)(5) for a takedown from an existing shelf registration statement.

Open the filing on SEC.gov

Filing facts

Accession number: 0001193125-26-401385
Filer: Viking Therapeutics, Inc.
Ticker: VKTX
CIK: 0001607678
Form type: 424B5
Form description: Prospectus supplement
Filed at: September 25, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: September 25, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Viking Therapeutics, Inc.

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1607678/000119312526401385/0001193125-26-401385-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Viking Therapeutics, Inc. (0001607678) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001193125-26-401385.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.